Global Vitamin K Antagonists (VKA) Market Insights and Forecast to 2026

Global Vitamin K Antagonists (VKA) Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Vitamin K Antagonists (VKA) Product Introduction
1.2 Market Segments
1.3 Key Vitamin K Antagonists (VKA) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type
1.4.2 Oral Vitamin K Antagonists
1.4.3 Injection Vitamin K Antagonists
1.5 Market by Application
1.5.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application
1.5.2 VTE
1.5.3 ACS/MI
1.5.4 AF
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vitamin K Antagonists (VKA) Market Size, Estimates and Forecasts
2.1.1 Global Vitamin K Antagonists (VKA) Revenue 2015-2026
2.1.2 Global Vitamin K Antagonists (VKA) Sales 2015-2026
2.2 Global Vitamin K Antagonists (VKA), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Vitamin K Antagonists (VKA) Competitor Landscape by Players
3.1 Vitamin K Antagonists (VKA) Sales by Manufacturers
3.1.1 Vitamin K Antagonists (VKA) Sales by Manufacturers (2015-2020)
3.1.2 Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2015-2020)
3.2 Vitamin K Antagonists (VKA) Revenue by Manufacturers
3.2.1 Vitamin K Antagonists (VKA) Revenue by Manufacturers (2015-2020)
3.2.2 Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vitamin K Antagonists (VKA) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vitamin K Antagonists (VKA) Revenue in 2019
3.2.5 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vitamin K Antagonists (VKA) Price by Manufacturers
3.4 Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Types
3.4.1 Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vitamin K Antagonists (VKA) Product Type
3.4.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vitamin K Antagonists (VKA) Market Size by Type (2015-2020)
4.1.1 Global Vitamin K Antagonists (VKA) Sales by Type (2015-2020)
4.1.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2015-2020)
4.1.3 Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vitamin K Antagonists (VKA) Market Size Forecast by Type (2021-2026)
4.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2021-2026)
4.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Type (2021-2026)
4.2.3 Vitamin K Antagonists (VKA) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vitamin K Antagonists (VKA) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Vitamin K Antagonists (VKA) Market Size by Application (2015-2020)
5.1.1 Global Vitamin K Antagonists (VKA) Sales by Application (2015-2020)
5.1.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2015-2020)
5.1.3 Vitamin K Antagonists (VKA) Price by Application (2015-2020)
5.2 Vitamin K Antagonists (VKA) Market Size Forecast by Application (2021-2026)
5.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2021-2026)
5.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2021-2026)
5.2.3 Global Vitamin K Antagonists (VKA) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Vitamin K Antagonists (VKA) by Country
6.1.1 North America Vitamin K Antagonists (VKA) Sales by Country
6.1.2 North America Vitamin K Antagonists (VKA) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Type
6.3 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Application
7 Europe
7.1 Europe Vitamin K Antagonists (VKA) by Country
7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Country
7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Type
7.3 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Vitamin K Antagonists (VKA) by Region
8.1.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region
8.1.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Type
8.3 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Vitamin K Antagonists (VKA) by Country
9.1.1 Latin America Vitamin K Antagonists (VKA) Sales by Country
9.1.2 Latin America Vitamin K Antagonists (VKA) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vitamin K Antagonists (VKA) Market Facts & Figures by Type
9.3 Central & South America Vitamin K Antagonists (VKA) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Vitamin K Antagonists (VKA) by Country
10.1.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country
10.1.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Type
10.3 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
11.1.5 Sanofi Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered
11.3.5 Bayer Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Corporation Information
11.5.2 Genentech (Roche) Description and Business Overview
11.5.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered
11.5.5 Genentech (Roche) Related Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Description and Business Overview
11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered
11.6.5 Boehringer Ingelheim Related Developments
11.7 Lilly
11.7.1 Lilly Corporation Information
11.7.2 Lilly Description and Business Overview
11.7.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered
11.7.5 Lilly Related Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Corporation Information
11.8.2 Daiichi Sankyo Description and Business Overview
11.8.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered
11.8.5 Daiichi Sankyo Related Developments
11.9 Otsuka
11.9.1 Otsuka Corporation Information
11.9.2 Otsuka Description and Business Overview
11.9.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered
11.9.5 Otsuka Related Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Description and Business Overview
11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered
11.10.5 AstraZeneca Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
11.1.5 Sanofi Related Developments
11.12 Aspen
11.12.1 Aspen Corporation Information
11.12.2 Aspen Description and Business Overview
11.12.3 Aspen Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Aspen Products Offered
11.12.5 Aspen Related Developments
11.13 The Medicines Company
11.13.1 The Medicines Company Corporation Information
11.13.2 The Medicines Company Description and Business Overview
11.13.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
11.13.4 The Medicines Company Products Offered
11.13.5 The Medicines Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vitamin K Antagonists (VKA) Market Estimates and Projections by Region
12.1.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Regions 2021-2026
12.1.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Regions 2021-2026
12.2 North America Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
12.2.1 North America: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
12.2.2 North America: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
12.2.3 North America: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
12.3 Europe Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
12.3.1 Europe: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
12.3.2 Europe: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
12.3.3 Europe: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vitamin K Antagonists (VKA) Market Size Forecast by Region (2021-2026)
12.5 Latin America Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
12.5.1 Latin America: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
12.5.2 Latin America: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
12.5.3 Latin America: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Vitamin K Antagonists (VKA) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vitamin K Antagonists (VKA) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Vitamin K Antagonists (VKA) Market Segments
Table 2. Ranking of Global Top Vitamin K Antagonists (VKA) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral Vitamin K Antagonists
Table 5. Major Manufacturers of Injection Vitamin K Antagonists
Table 6. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Vitamin K Antagonists (VKA) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Vitamin K Antagonists (VKA) Sales by Regions 2015-2020 (K MT)
Table 9. Global Vitamin K Antagonists (VKA) Sales Market Share by Regions (2015-2020)
Table 10. Global Vitamin K Antagonists (VKA) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Vitamin K Antagonists (VKA) Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturers (2015-2020)
Table 13. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vitamin K Antagonists (VKA) as of 2019)
Table 15. Vitamin K Antagonists (VKA) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Vitamin K Antagonists (VKA) Price (2015-2020) (USD/MT)
Table 18. Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Vitamin K Antagonists (VKA) Product Type
Table 20. Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Vitamin K Antagonists (VKA) Sales by Type (2015-2020) (K MT)
Table 23. Global Vitamin K Antagonists (VKA) Sales Share by Type (2015-2020)
Table 24. Global Vitamin K Antagonists (VKA) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Vitamin K Antagonists (VKA) Revenue Share by Type (2015-2020)
Table 26. Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Vitamin K Antagonists (VKA) Sales by Application (2015-2020) (K MT)
Table 28. Global Vitamin K Antagonists (VKA) Sales Share by Application (2015-2020)
Table 29. North America Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 30. North America Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 31. North America Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 33. North America Vitamin K Antagonists (VKA) Sales by Type (2015-2020) (K MT)
Table 34. North America Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
Table 35. North America Vitamin K Antagonists (VKA) Sales by Application (2015-2020) (K MT)
Table 36. North America Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Table 37. Europe Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 38. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 39. Europe Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 41. Europe Vitamin K Antagonists (VKA) Sales by Type (2015-2020) (K MT)
Table 42. Europe Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
Table 43. Europe Vitamin K Antagonists (VKA) Sales by Application (2015-2020) (K MT)
Table 44. Europe Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Vitamin K Antagonists (VKA) Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Vitamin K Antagonists (VKA) Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Table 53. Latin America Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 54. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Vitamin K Antagonists (VKA) Sales by Type (2015-2020) (K MT)
Table 58. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
Table 59. Latin America Vitamin K Antagonists (VKA) Sales by Application (2015-2020) (K MT)
Table 60. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Table 69. Sanofi Corporation Information
Table 70. Sanofi Description and Major Businesses
Table 71. Sanofi Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Sanofi Product
Table 73. Sanofi Recent Development
Table 74. Bristol-Myers Squibb Corporation Information
Table 75. Bristol-Myers Squibb Description and Major Businesses
Table 76. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Bristol-Myers Squibb Product
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Bayer Corporation Information
Table 80. Bayer Description and Major Businesses
Table 81. Bayer Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Bayer Product
Table 83. Bayer Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Genentech (Roche) Corporation Information
Table 90. Genentech (Roche) Description and Major Businesses
Table 91. Genentech (Roche) Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Genentech (Roche) Product
Table 93. Genentech (Roche) Recent Development
Table 94. Boehringer Ingelheim Corporation Information
Table 95. Boehringer Ingelheim Description and Major Businesses
Table 96. Boehringer Ingelheim Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Boehringer Ingelheim Product
Table 98. Boehringer Ingelheim Recent Development
Table 99. Lilly Corporation Information
Table 100. Lilly Description and Major Businesses
Table 101. Lilly Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Lilly Product
Table 103. Lilly Recent Development
Table 104. Daiichi Sankyo Corporation Information
Table 105. Daiichi Sankyo Description and Major Businesses
Table 106. Daiichi Sankyo Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Daiichi Sankyo Product
Table 108. Daiichi Sankyo Recent Development
Table 109. Otsuka Corporation Information
Table 110. Otsuka Description and Major Businesses
Table 111. Otsuka Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Otsuka Product
Table 113. Otsuka Recent Development
Table 114. AstraZeneca Corporation Information
Table 115. AstraZeneca Description and Major Businesses
Table 116. AstraZeneca Vitamin K Antagonists (VKA) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. AstraZeneca Product
Table 118. AstraZeneca Recent Development
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Major Businesses
Table 121. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Pfizer Product
Table 123. Pfizer Recent Development
Table 124. Aspen Corporation Information
Table 125. Aspen Description and Major Businesses
Table 126. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Aspen Product
Table 128. Aspen Recent Development
Table 129. The Medicines Company Corporation Information
Table 130. The Medicines Company Description and Major Businesses
Table 131. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. The Medicines Company Product
Table 133. The Medicines Company Recent Development
Table 134. Global Vitamin K Antagonists (VKA) Sales Forecast by Regions (2021-2026) (K MT)
Table 135. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Vitamin K Antagonists (VKA) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Vitamin K Antagonists (VKA) Sales Forecast by Country (2021-2026) (K MT)
Table 139. North America: Vitamin K Antagonists (VKA) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Vitamin K Antagonists (VKA) Sales Forecast by Country (2021-2026) (K MT)
Table 141. Europe: Vitamin K Antagonists (VKA) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Vitamin K Antagonists (VKA) Sales Forecast by Region (2021-2026) (K MT)
Table 143. Asia Pacific: Vitamin K Antagonists (VKA) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Vitamin K Antagonists (VKA) Sales Forecast by Country (2021-2026) (K MT)
Table 145. Latin America: Vitamin K Antagonists (VKA) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Vitamin K Antagonists (VKA) Sales Forecast by Country (2021-2026) (K MT)
Table 147. Middle East and Africa: Vitamin K Antagonists (VKA) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Vitamin K Antagonists (VKA) Players
Table 152. Vitamin K Antagonists (VKA) Customers List
Table 153. Vitamin K Antagonists (VKA) Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitamin K Antagonists (VKA) Product Picture
Figure 2. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Vitamin K Antagonists Product Picture
Figure 4. Injection Vitamin K Antagonists Product Picture
Figure 5. Global Vitamin K Antagonists (VKA) Sales Market Share by Application in 2020 & 2026
Figure 6. VTE
Figure 7. ACS/MI
Figure 8. AF
Figure 9. Others
Figure 10. Vitamin K Antagonists (VKA) Report Years Considered
Figure 11. Global Vitamin K Antagonists (VKA) Market Size 2015-2026 (US$ Million)
Figure 12. Global Vitamin K Antagonists (VKA) Sales 2015-2026 (K MT)
Figure 13. Global Vitamin K Antagonists (VKA) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2015-2020)
Figure 15. Global Vitamin K Antagonists (VKA) Sales Market Share by Region in 2019
Figure 16. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2015-2020)
Figure 17. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region in 2019
Figure 18. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Vitamin K Antagonists (VKA) Revenue in 2019
Figure 20. Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
Figure 22. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2019
Figure 23. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2015-2020)
Figure 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type in 2019
Figure 25. Global Vitamin K Antagonists (VKA) Market Share by Price Range (2015-2020)
Figure 26. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Figure 27. Global Vitamin K Antagonists (VKA) Sales Market Share by Application in 2019
Figure 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2015-2020)
Figure 29. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application in 2019
Figure 30. North America Vitamin K Antagonists (VKA) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Vitamin K Antagonists (VKA) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Vitamin K Antagonists (VKA) Sales Market Share by Country in 2019
Figure 33. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2019
Figure 34. U.S. Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Vitamin K Antagonists (VKA) Market Share by Type in 2019
Figure 39. North America Vitamin K Antagonists (VKA) Market Share by Application in 2019
Figure 40. Europe Vitamin K Antagonists (VKA) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Vitamin K Antagonists (VKA) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country in 2019
Figure 43. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2019
Figure 44. Germany Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Vitamin K Antagonists (VKA) Market Share by Type in 2019
Figure 55. Europe Vitamin K Antagonists (VKA) Market Share by Application in 2019
Figure 56. Asia Pacific Vitamin K Antagonists (VKA) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Vitamin K Antagonists (VKA) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region in 2019
Figure 59. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region in 2019
Figure 60. China Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Vitamin K Antagonists (VKA) Market Share by Type in 2019
Figure 83. Asia Pacific Vitamin K Antagonists (VKA) Market Share by Application in 2019
Figure 84. Latin America Vitamin K Antagonists (VKA) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Vitamin K Anta

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs